Category: Workers Comp

517 posts found

Marijuana Bills Could Create Protections for Employment Discrimination

Testing positive for marijuana use could one day no longer prohibit employment.

With a flurry of opioid developments lately, what does the big picture look like?

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

Does the active ingredient in magic mushrooms have a future in mental health?

Phase 3 studies are underway, and current research sees potential for MDMA in psychotherapy.

A recent meta-analysis of over 100 trials and studies found lavender to significantly reduce anxiety levels.

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

Understand how prices are set for medical equipment and services, and how to scrutinize those costs.

According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.

Beyond compensability, Minnesota considers rules for evaluation, treatment planning, acceptable psychotherapies, and more.

Workers’ comp publications cover Healthesystems content surrounding aging physicians, successful return-to-work programs, and more.

A previous gastrointestinal drug recall expands, while a new recall for an anxiety drug is issued.

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

Shortly after California made strides on employee classification for gig economy jobs, New Jersey and New York have taken action.

The Society of Actuaries published a report that claims the economic burden of the opioid epidemic was $631 billion from 2015-2018.

Prev 1 2 3 4 5 … 25 26 27 28 29 … 31 32 33 34 35 Next